The MSK-Cornell Center for Translation of Cancer Nanomedicine was funded to advance, translate, and disseminate a suite of ultrasmall (less than 10 nm) silica-organic hybrid nanoparticles with tunable size, brightness, and geometry that have the potential to dramatically impact the way we diagnose and treat cancer patients based on their favorable physicochemical and imaging properties. This includes the development and implementation of intraoperative optical detection tools to improve cancer localization, staging, and treatment, as well as the development of optimized therapeutic platforms that enhance delivery and therapeutic index relative to existing technologies.
Part of the U54 grant that funds the MSK-Cornell Center for Translation of Cancer Nanomedicine is a Developmental Program under the lead of PI Dr. Jason Lewis – Radiology which exists to:
- Support high-risk and emerging opportunities that will contribute to the overall success of the U54 Center and augment the Center’s vision and strategic goals in accordance with the objectives defined and elaborated on above.
- Identify Pilot Projects (PPs) that will generate additional funding (e.g., R01) from the data generated. Ideally these Pilot Projects, driven primarily by junior faculty members, should provide an avenue to generate preliminary data for a subsequent application for extramural funding.
If you are seeking to fund a Pilot Project through this program, please download and review the full call from the sidebar.
NOTE: The deadline for this call has passed. Deadline for submission was January 29th, 2016. The next call for applications will be late Summer 2016.